Ceribell (CBLL) Other financing activities (2024 - 2025)

Ceribell (CBLL) reported Other financing activities of $63000.0 for Q3 2025, down 76.49% quarter-over-quarter from $268000.0 in Q2 2025.

Ceribell (CBLL) Other financing activities (2024 - 2025) Analysis & Trends

Ceribell has reported Other financing activities for 2 years, with the latest figure at $63000.0 in Q3 2025.

For the quarter ending Q3 2025, Other financing activities changed N/A year-over-year to $63000.0; the trailing twelve-month figure through Mar 2026 stood at $331000.0 (up 203.67% YoY), and the FY2025 full-year result was $150000.0, down 50.66% from the prior year.
Other financing activities for Q3 2025 stood at $63000.0, down from $268000.0 in the prior quarter.
The five-year high for Other financing activities was $345000.0 in Q1 2024, with the low at -$41000.0 in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn
10	Ceribell	695.83 Mn	554.65 Mn	23.12 Mn

Download Data